Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.40 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.40 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.40 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.40 |
| ▸ | PYGB | P11216 | 5/20 | 0.38 |
| ▸ | PYGL | P06737 | 3/20 | 0.38 |
| ▸ | PYGM | P11217 | 2/20 | 0.38 |
| ▸ | CDK1 | P06493 | 1/20 | 0.37 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31175314 | 1.00 | MEN1 (0.41) | MEN1KMT2ALGALS1LGALS3LGALS9 | |
| SCHEMBL2216585 | 1.00 | MEN1 (0.41) | MEN1KMT2ALGALS1LGALS3LGALS9 | |
| SCHEMBL2218756 | 1.00 | MEN1 (0.41) | MEN1KMT2ALGALS1LGALS3LGALS9 | |
| SCHEMBL31310161 | 1.00 | MEN1 (0.41) | MEN1KMT2ALGALS1LGALS3LGALS9 | |
| SCHEMBL3459153 | 1.00 | MEN1 (0.41) | MEN1KMT2ALGALS1LGALS3LGALS9 | |
| SCHEMBL29932427 | 0.87 | PYGB (0.35) | MEN1KMT2APYGBPYGLPYGM | |
| SCHEMBL31150917 | 0.83 | CA1 (0.38) | MEN1KMT2ALGALS1LGALS3LGALS9 | |
| SCHEMBL9950844 | 0.82 | MEN1 (0.35) | MEN1KMT2ALGALS1LGALS3LGALS9 | |
| SCHEMBL30380443 | 0.81 | MEN1 (0.61) | MEN1KMT2ALGALS3LGALS8 | |
| SCHEMBL29350139 | 0.81 | MEN1 (0.61) | MEN1KMT2ALGALS3LGALS8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0879048-B2 | Method for making tablets using trehalose | QUADRANT DRUG DELIVERY LTD (GB) | 2009-07-29 | — | — | EP | disclosed |
| EP-0879048-B1 | SOLID FORMULATIONS CONTAINING TREHALOSE | QUADRANT DRUG DELIVERY LTD (GB) | 2004-04-28 | — | — | EP | disclosed |
| EP-0879048-A1 | SOLID FORMULATIONS CONTAINING TREHALOSE | QUADRANT HOLDINGS CAMBRIDGE LIMITED (GB) | 1998-11-25 | — | — | EP | disclosed |
| WO-1997028788-A1 | SOLID FORMULATIONS CONTAINING TREHALOSE | QUADRANT HOLDINGS CAMBRIDGE LTD. (GB) | 1997-08-14 | — | — | WO | disclosed |